Editorial: Sorafenib Toxicity, a Biomarker of Effect?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Sorafenib Toxicity, a Biomarker of Effect? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Combination Therapy: Intermittent Sorafenib With Bevacizumab Yields Activity and Decreased Toxicity

British Journal of Cancer
Cancer ResearchOncology
2010English

Oxidative Stress in Triazine Pesticide Toxicity: A Review of the Main Biomarker Findings

Arhiv za Higijenu Rada i Toksikologiju
EnvironmentalPublic HealthToxicologyOccupational Health
2018English

A Novel Biomarker for Cellular Toxicity and Phospholipid Accumulation by Cationic Amphiphilic Drugs

CHROMATOGRAPHY
2016English

Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib

PLoS ONE
Multidisciplinary
2011English

Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases

Frontiers in Neurology
Neurology
2019English

Bufalin Enhances Anti-Angiogenic Effect of Sorafenib via AKT/VEGF Signaling

International Journal of Oncology
Cancer ResearchOncology
2016English

Effect of Sorafenib on Des‑γ‑carboxyprothrombin Secretion by a Human Hepatocellular Carcinoma Cell Line

Oncology Letters
Cancer ResearchOncology
2017English

Triclosan Treatment Decreased the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy